Prevalence of Clopidogrel (Plavix) Resistance in Hemodialysis Patients

Completed

Conditions studied: Cardiovascular Disease

In brief

The investigators are trying to find out if Clopidogrel (Plavix) is as effective in hemodialysis patients as in patients not hemodialysed.

Key facts

Study ID

NCT01865890

Run by

Northwell Health

People needed

100

Starts

2010-06-01

Expected to finish

2011-04-01

Last updated by the study team

2013-05-31

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• All patients on hemodialysis taking Plavix

You may not qualify if…

• known to have bleeding disorder
• Severely anemic with hemoglobin level (Hb) < 10g/dl
• Low Platelets < 10000

Where it is running

• Staten Island University Hospital — Staten Island, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.